MagDI U.S. Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorGT Metabolic Solutions, Inc.
About this trial
Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
Eligibility criteria
Qualifiers
>21 years of age, at the time of informed consent.
Body Mass Index (BMI) between 30-50 kg/m2.
Indicated for a side-to-side duodeno-ileal anastomosis and is treated with the MagDI System at a U.S. registry center.
Participant has been informed of the nature of the registry.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Side-to-side duodenal-ileal anastomosis
Treatment groups
106 Participants
are divided into 1 treatment groupLocations
5Ventura Advanced Surgical Associates93003, VenturaCalifornia, United States
Baptist Healthcare System, Inc.40299, LouisvilleKentucky, United States
Ochsner Clinic Foundation70503, LafayetteLouisiana, United States
Bariatric Specialists of the Carolinas27518, CaryNorth Carolina, United States
Sponsors and collaborators
GT Metabolic Solutions, Inc.
Lead sponsor
Source ClinicalTrials.gov